Krystal Biotech
KRYS
KRYS
274 hedge funds and large institutions have $3.8B invested in Krystal Biotech in 2025 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 100 increasing their positions, 98 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
11% less call options, than puts
Call options by funds: $60.6M | Put options by funds: $68M
23% less capital invested
Capital invested by funds: $4.93B → $3.8B (-$1.13B)
35% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 63
Holders
274
Holding in Top 10
7
Calls
$60.6M
Puts
$68M
Top Buyers
| 1 | +$66.1M | |
| 2 | +$45M | |
| 3 | +$40.8M | |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$26M |
| 5 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
+$20.3M |
Top Sellers
| 1 | -$46.9M | |
| 2 | -$33.5M | |
| 3 | -$27.3M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$25.2M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$24.5M |
